PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

168 hedge funds and large institutions have $1.36B invested in Pacira BioSciences in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
-17
Holders Change %
-9.19%
% of All Funds
3.86%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.05%
New
27
Increased
58
Reduced
60
Closed
42
Calls
$12M
Puts
$27.9M
Net Calls
-$15.9M
Net Calls Change
-$27.9M

Top Buyers

1
PHS
1
PFM Health Sciences
California
$53.1M
2
CCM
2
Consonance Capital Management
New York
$82.1M
3
ACA
3
Avoro Capital Advisors
New York
$53.4M
4
PC
4
PointState Capital
New York
$63.5M
5
Jennison Associates
5
Jennison Associates
New York
$16M

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
VOYA Investment Management
2
VOYA Investment Management
Georgia
$547K
3
CHP
3
Castle Hook Partners
New York
$0
4
HM
4
HealthCor Management
New York
$71.6M
5
Invesco
5
Invesco
Georgia
$5.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
EWM
201
Evercore Wealth Management
New York
– -$156K -3,409 Closed
QI
202
QS Investors
New York
– -$151K -3,300 Closed
II
203
Inspire Investing
Idaho
– -$59K -1,298 Closed
DSN
204
D. Scott Neal
Kentucky
– -$9K -200 Closed
KF
205
Krilogy Financial
Missouri
– -$9K -200 Closed
5 6 7 8
9